References to US operations describe warehouse fulfillment only and do not represent a separate US manufacturer, clinic, medical provider, supplement company, or pharmaceutical entity
According to the American Diabetes Association and the European Association for the Study of Diabetes, metformin therapy, together with lifestyle intervention, should be initiated at the time of diagnosis of type 2 diabetes
Safety across the full program was consistently favorable: adverse events, primarily mild headache and gastrointestinal symptoms, occurred at rates comparable to placebo, with no treatment-related discontinuations, no IGF-1 elevation, and no impact on glucose metabolism
Understanding this connection might open new doors to improving health and quality of life for many
FDA-approved compound that stimulates GH production